<DOC>
	<DOC>NCT02915211</DOC>
	<brief_summary>To evaluate the tolerance, acceptability and compliance of Keyo in 20 subjects aged 3 years and over, with intractable epilepsy or Glut-1 DS on a KD.</brief_summary>
	<brief_title>Evaluation of Keyo in Children With Epilepsy</brief_title>
	<detailed_description>Qualitative assessments from subject questionnaires that allow evaluation of the acceptability and ease of use of the study product. Collection of daily data about the gastro-intestinal tolerance of the study product. Collection of daily data about compliance with the study product i.e. actual versus prescribed intake. Improve quality of life by increasing range of foods available for use in a ketogenic diet.</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<mesh_term>Carbohydrate Metabolism, Inborn Errors</mesh_term>
	<criteria>3 years and over Confirmed diagnosis of intractable epilepsy or Glut1 DS Children must be currently established on a KD for at least 3 months, taken orally Written, informed consent by participant/carer</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Glut</keyword>
	<keyword>Ketogenic</keyword>
	<keyword>Glucose</keyword>
</DOC>